No Racial Difference in Recurrence-Free Survival in HR+, HER2- Breast Cancer

Race demonstrated differences in overall survival outcomes, but not for three-year recurrence-free survival in patients with HR-positive, HER2-negative breast cancer, according to data.

Related Keywords

Tennessee ,United States ,San Antonio ,Texas ,Vanderbilt University ,Sonya Reid ,Vanderbilt University Medical Center , ,Antonio Breast Cancer ,Thenew England Journal ,Basal Type ,Clinical Oncology ,Breast Cancer ,Conference ,News ,